中国医药

- 600056

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
中国医药(600056) 利润表
单位:万元
报表日期2022-09-302022-06-302022-03-312021-12-312021-09-30
一、营业总收入2,691,723.001,765,145.38851,990.193,623,441.472,672,805.27
营业收入2,691,723.001,765,145.38851,990.193,623,441.472,672,805.27
二、营业总成本2,579,065.551,676,256.48817,148.933,448,096.372,553,620.09
营业成本2,347,550.151,527,194.31740,377.573,101,823.852,300,433.07
营业税金及附加8,599.745,972.692,958.769,891.777,228.76
销售费用137,763.3989,459.8046,778.20219,951.52164,056.81
管理费用68,086.8244,114.6922,063.6688,521.8963,627.17
财务费用12,166.476,279.543,501.0522,169.1514,659.87
研发费用4,898.983,235.451,469.695,738.203,614.41
资产减值损失----------
公允价值变动收益-35.58-35.54---213.54--
投资收益5,059.583,790.12-4.764,365.684,920.48
其中:对联营企业和合营企业的投资收益9,157.695,347.19647.1911,390.027,262.91
汇兑收益----------
三、营业利润122,875.0496,087.9538,198.9593,713.48125,780.57
加:营业外收入1,553.43984.43700.451,936.441,141.49
减:营业外支出902.87863.5643.131,639.30784.92
其中:非流动资产处置损失----------
四、利润总额123,525.6096,208.8338,856.2794,010.62126,137.14
减:所得税费用29,720.0123,040.478,772.3922,583.0124,927.12
五、净利润93,805.5973,168.3530,083.8771,427.61101,210.03
归属于母公司所有者的净利润76,671.3761,601.9824,598.0164,705.7183,561.30
少数股东损益17,134.2211,566.385,485.866,721.9117,648.72
六、每股收益
基本每股收益(元/股)0.51260.41180.23020.60560.7821
稀释每股收益(元/股)0.51260.41180.23020.60560.7821
七、其他综合收益-69.80-81.75---206.68-8.40
八、综合收益总额93,735.7973,086.6030,083.8771,220.94101,201.62
归属于母公司所有者的综合收益总额76,601.5761,520.2324,598.0164,555.5183,552.90
归属于少数股东的综合收益总额17,134.2211,566.385,485.866,665.4317,648.72
下载全部历史数据到excel中 返回页顶